Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00120835
What this trial is testing

Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Not applicableUnknownNCT05372874
What this trial is testing

Treatment of Hepatitis c by Using Direct-acting Antiviral

Who this might be right for
Hepatitis C
Tanta University 50
Large-scale testing (Phase 3)Study completedNCT01674725
What this trial is testing

Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Subjects With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 187
Large-scale testing (Phase 3)Study completedNCT02105688
What this trial is testing

An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus (HCV) Genotype (GT)1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 301
Post-approval studies (Phase 4)Study completedNCT00575224
What this trial is testing

Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9

Who this might be right for
Chronic Hepatitis CAsian AmericansNovel Genotypes+1 more
Pacific Health Foundation 60
Post-approval studies (Phase 4)Study completedNCT00940420
What this trial is testing

Combination Treatment With Pegasys (Peginterferon Alfa) and Copegus (Ribavirin)in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 2,695
Early research (Phase 1)Study completedNCT00960479
What this trial is testing

Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Fasting Conditions

Who this might be right for
Chronic Hepatitis C
Sandoz 38
Testing effectiveness (Phase 2)Study completedNCT01932762
What this trial is testing

Efficacy and Safety of Combination Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin (RBV) in Genotype 2 Hepatitis C Infection (MK-5172-047)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 98
Testing effectiveness (Phase 2)Study completedNCT02569710
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335, Odalasvir, and Simeprevir

Who this might be right for
Chronic Hepatitis C
Alios Biopharma Inc. 161
Not applicableUnknownNCT03042520
What this trial is testing

Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment

Who this might be right for
Liver FibrosesHepatoCellular CarcinomaCryoglobulinemia+2 more
Kaohsiung Medical University Chung-Ho Memorial Hospital 200
Not applicableUnknownNCT03572140
What this trial is testing

Safety of Sofosbuvir ,Daclatasvir in HCV Patients and RAVS in Resistent and Relapsed Cases

Who this might be right for
HCV
Assiut University 297
Testing effectiveness (Phase 2)Study completedNCT01356160
What this trial is testing

GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 351
Post-approval studies (Phase 4)Active Not RecruitingNCT03520660
What this trial is testing

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Who this might be right for
Diabetes MellitusHepatitis C, ChronicCardiovascular Diseases
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 121
Testing effectiveness (Phase 2)Study completedNCT02536313
What this trial is testing

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination With or Without Ribavirin in Participants With Chronic Genotype 1 HCV Infection Previously Treated With a Direct Acting Antiviral Regimen

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 49
Early research (Phase 1)Study completedNCT01803308
What this trial is testing

A Multiple Ascending Dose Phase I Study of SB 9200 in Treatment Naïve Adults With Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C Infection
Syneos Health 37
Early research (Phase 1)Study completedNCT01193478
What this trial is testing

A Multiple Ascending Dose Study of GS 5885 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
HCV Infection
Gilead Sciences 71
Post-approval studies (Phase 4)WithdrawnNCT03093740
What this trial is testing

Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant

Who this might be right for
Renal Failure ChronicHepatitis C
Massachusetts General Hospital
Early research (Phase 1)Study completedNCT00565539
What this trial is testing

Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
ZymoGenetics 56
Testing effectiveness (Phase 2)Study completedNCT02716428
What this trial is testing

Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Viral InfectionChronic Hepatitis CHepatitis C (HCV)+1 more
Trek Therapeutics, PBC 25
Large-scale testing (Phase 3)Study completedNCT00093093
What this trial is testing

Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive

Who this might be right for
Chronic Hepatitis C
Bausch Health Americas, Inc. 900
Next Page